ARTICLE | Clinical News
AGIL-AADC regulatory update
November 22, 2016 12:39 AM UTC
FDA granted rare pediatric disease designation to Agilis’ AGIL-AADC to treat Aromatic L-Amino Acid Decarboxylase (AADC) deficiency. The product is an adeno-associated viral (AAV) vector encoding the d...
BCIQ Company Profiles
BCIQ Target Profiles